[Highly active interferon in the combined treatment of patients with meningoencephalitis]

Area of Science:

• Neurology
• Virology
• Bacteriology
• Immunology

Background:

• Nervous system diseases of viral-bacterial etiology pose significant clinical challenges.
• Current treatment regimens may not fully address the complexities of these infections.
• The role of immunomodulatory agents like interferon in such conditions warrants further investigation.

Purpose of the Study:

• To evaluate the efficacy of high-active interferon as part of complex treatment for nervous system diseases.
• To assess the impact of early interferon intervention on clinical outcomes and disease progression.

Main Methods:

• A cohort of 49 patients with viral-bacterial nervous system diseases received complex treatment including high-active interferon.
• A control group of 28 similar patients was analyzed for comparison.
• Clinical effects, symptom duration, cerebrospinal fluid (CSF) healing, disease progression, and lethality were monitored.

Main Results:

• Early administration of high-active interferon led to a positive clinical effect.
• Patients receiving interferon experienced a milder clinical course and reduced duration of symptoms.
• Interferon treatment enhanced CSF healing, prevented protracted disease forms, and reduced lethality by 2.9 times.

Conclusions:

• High-active interferon is a valuable component in the complex treatment of viral-bacterial nervous system diseases.
• Early intervention with interferon demonstrates significant benefits in reducing disease severity and mortality.
• Further research into interferon's immunomodulatory mechanisms in neurological infections is recommended.